Exchange: NYSE·Updated 04:15 PM EDT
News
all
press releases
Is This the Right Time to Add PBH Stock to Your Portfolio?
Prestige Consumer Healthcare gains from acquisitions, e-commerce growth and strong cash flow, though currency swings and high debt remain key risks.
Zacks
More News
Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek Football Stress Test
Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek Football Stress Test Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek Football Stress Test PR Newswire TARRYTOWN, N.Y., Sept. 1, 2026 National survey commissioned by DenTek, the #1 OTC...
PR Newswire
PBH vs. SYK: Which Stock Is the Better Value Option?
PBH vs. SYK: Which Stock Is the Better Value Option?
Zacks
Nearly 40,000 eye drops recalled nationwide over possible contamination
Nearly 40,000 bottles of eye drops are being recalled nationwide due to potential contamination, according to the Food and Drug Administration.Tarrytown, New York-based Prestige Brand Holdings is voluntarily recalling 39,060 bottles of its Clear Eyes Maximum Itchy Eye Relief eye drops due to a...
FOXBusiness.com - Business/Financial
Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
PBH or SYK: Which Is the Better Value Stock Right Now?
PBH vs. SYK: Which Stock Is the Better Value Option?
Zacks
PBH Stock Up on Q1 Earnings and Revenue Beat, Fiscal '27 View Raised
Prestige Consumer's Q1 earnings and revenues outpace estimates as acquisitions boost its fiscal 2027 outlook despite margin pressure.
Zacks
Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Prestige Consumer Healthcare (PBH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
Prestige Consumer Healthcare (PBH) Q1 Earnings and Revenues Surpass Estimates
Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of +10.11% and +6.18%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
InfuSystems Holdings, Inc. (INFU) Q2 Earnings and Revenues Surpass Estimates
InfuSystems Holdings (INFU) delivered earnings and revenue surprises of +25.00% and +1.19%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.